Home
/
CRYO CELL INTERNATIONAL INC
/
Financials
/
Quarterly
CRYO CELL INTERNATIONAL INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that CRYO CELL INTERNATIONAL INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2018
May 31, 2018
$6.53M
Jul 16, 2018
Q1
2018
Feb 28, 2018
$6.23M
Apr 16, 2018
Q3
2017
Aug 31, 2017
$6.90M
Oct 16, 2017
Q2
2018
May 31, 2017
$6.24M
Jul 16, 2018
Q1
2018
Feb 28, 2017
$5.78M
Apr 16, 2018
Q3
2017
Aug 31, 2016
$6.33M
Oct 16, 2017
Q2
2017
May 31, 2016
$5.77M
Jul 7, 2017
Q1
2017
Feb 29, 2016
$5.15M
Apr 13, 2017
Q3
2016
Aug 31, 2015
$5.44M
Oct 17, 2016
Q2
2016
May 31, 2015
$5.01M
Jul 11, 2016
Q1
2016
Feb 28, 2015
$4.84M
Apr 14, 2016
Q3
2015
Aug 31, 2014
$4.94M
Oct 15, 2015
Q2
2015
May 31, 2014
$4.89M
Jul 15, 2015
Q1
2015
Feb 28, 2014
$5.32M
Apr 14, 2015
Q3
2014
Aug 31, 2013
$4.83M
Oct 15, 2014
Q2
2014
May 31, 2013
$4.86M
Jul 3, 2014
Q1
2014
Feb 28, 2013
$4.60M
Apr 14, 2014
Q3
2013
Aug 31, 2012
$4.54M
Oct 15, 2013
Q2
2013
May 31, 2012
$4.43M
Jul 15, 2013
Q1
2013
Feb 29, 2012
$4.18M
Apr 15, 2013
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2026
Feb 28, 2026
$47.1K
Apr 14, 2026
Q3
2025
Aug 31, 2025
$749.4K
Oct 15, 2025
Q2
2025
May 31, 2025
$355.8K
Jul 15, 2025
Q1
2026
Feb 28, 2025
$282.9K
Apr 14, 2026
Q3
2025
Aug 31, 2024
$1.05M
Oct 15, 2025
Q2
2025
May 31, 2024
$655.8K
Jul 15, 2025
Q1
2025
Feb 29, 2024
$556.2K
Apr 14, 2025
Q3
2024
Aug 31, 2023
$680.6K
Oct 15, 2024
Q2
2024
May 31, 2023
$221.0K
Jul 15, 2024
Q1
2024
Feb 28, 2023
$766.8K
Apr 15, 2024
Q3
2023
Aug 31, 2022
$466.8K
Oct 12, 2023
Q2
2023
May 31, 2022
$634.7K
Jul 14, 2023
Q1
2023
Feb 28, 2022
$832.0K
Apr 21, 2023
Q3
2022
Aug 31, 2021
$856.5K
Oct 18, 2022
Q2
2022
May 31, 2021
$1.17M
Jul 11, 2022
Q1
2022
Feb 28, 2021
$693.6K
Apr 13, 2022
Q3
2021
Aug 31, 2020
$784.5K
Oct 15, 2021
Q2
2021
May 31, 2020
$953.3K
Jul 15, 2021
Q1
2021
Feb 29, 2020
$687.0K
Apr 14, 2021
Q3
2020
Aug 31, 2019
$1.12M
Oct 15, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2026
Feb 28, 2026
$765.1K
Apr 14, 2026
Q3
2025
Aug 31, 2025
$1.90M
Oct 15, 2025
Q2
2025
May 31, 2025
$1.49M
Jul 15, 2025
Q1
2026
Feb 28, 2025
$1.06M
Apr 14, 2026
Q3
2025
Aug 31, 2024
$1.39M
Oct 15, 2025
Q2
2025
May 31, 2024
$1.39M
Jul 15, 2025
Q1
2025
Feb 29, 2024
$821.2K
Apr 14, 2025
Q3
2024
Aug 31, 2023
$1.16M
Oct 15, 2024
Q2
2024
May 31, 2023
$1.03M
Jul 15, 2024
Q1
2024
Feb 28, 2023
$1.68M
Apr 15, 2024
Q3
2023
Aug 31, 2022
$954.3K
Oct 12, 2023
Q2
2023
May 31, 2022
$1.19M
Jul 14, 2023
Q1
2023
Feb 28, 2022
$1.47M
Apr 21, 2023
Q3
2022
Aug 31, 2021
$1.60M
Oct 18, 2022
Q2
2022
May 31, 2021
$2.00M
Jul 11, 2022
Q1
2022
Feb 28, 2021
$1.24M
Apr 13, 2022
Q3
2021
Aug 31, 2020
$2.48M
Oct 15, 2021
Q2
2021
May 31, 2020
$1.75M
Jul 15, 2021
Q1
2021
Feb 29, 2020
$1.25M
Apr 14, 2021
Q3
2020
Aug 31, 2019
$1.99M
Oct 15, 2020